Concepedia

Jean-Pierre Delord

JD

3

Publications

3.9K

Citations

3

H-Index

2015

Active since

Affiliations

Inserm(Current)

Institut Claudius Regaud

Jean-Pierre Delord is an author at Inserm specializing in cancer therapeutics, radiation oncology, and oncology.

Top concepts

Publications per year

2015–2020

3

Publications

3

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study

Aurélien Marabelle, Dung T. Le, Paolo A. Ascierto et al. · Journal of Clinical Oncology · 2019 · 2.8K citations · Full text

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial

Christophe Le Tourneau, Jean-Pierre Delord, Anthony Gonçalvès et al. · The Lancet Oncology · 2015 · 1.1K citations

, , +12

Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial

Célèste Lebbé, Antoîne Italiano, Nadine Houédé et al. · Targeted Oncology · 2020 · 14 citations

, , +7

Rows per page

1–3 of 3